Per Westermark
- Physiology top 0.05%
- Alzheimer's disease research and treatments 121
- Nephrology top 0.2%
- Parathyroid Disorders and Treatments 36
- Molecular Biology top 0.1%
- Amyloidosis: Diagnosis, Treatment, Outcomes 214
- Prion Diseases and Protein Misfolding 28
- Cell Biology top 0.2%
-
- Diabetes Treatment and Management 36
-
- Pancreatic function and diabetes 78
-
- Dermatological and Skeletal Disorders 41
-
- Trace Elements in Health 29
- Co-authors
- Gunilla T. WestermarkKnut SlettenErik WilanderKenneth H. JohnsonTimothy D. O’BrienGiampaolo MerliniGibbons G. CornwellChrister Wernstedt
- Journals
- Amyloid (48 papers)Biochemical and Biophysical Research Communications (21 papers)Scandinavian Journal of Immunology (15 papers)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Per Westermark
362 papers receiving 22.4k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Physiology 9.2k
- Nephrology 2.1k
- Molecular Biology 15.6k
- Cell Biology 3.1k
- Endocrinology, Diabetes and Metabolism 2.6k
Countries citing papers authored by Per Westermark
This map shows the geographic impact of Per Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Westermark more than expected).
Fields of papers citing papers by Per Westermark
This network shows the impact of papers produced by Per Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Westermark. The network helps show where Per Westermark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Per Westermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2021 | 8 | |
| 4 | 2019 | 110 | |
| 5 | 2008 | 35 | |
| 6 | 2005 | 37 | |
| 7 | 2003 | 22 | |
| 8 | Distribution of medin-amyloid in aging and in association with arterial diseases | 2001 | 3 |
| 9 | 2001 | 102 | |
| 10 | The pathogenesis of amyloidosis: understanding general principles [comment] | 1998 | 3 |
| 11 | 1998 | 47 | |
| 12 | 1998 | 27 | |
| 13 | Diagnosing amyloidosis [editorial] | 1996 | 19 |
| 14 | 1995 | 6 | |
| 15 | 1995 | 75 | |
| 16 | 1995 | 15 | |
| 17 | 1992 | 91 | |
| 18 | 1987 | 23 | |
| 19 | 1981 | 84 | |
| 20 | 1978 | 11 |
About Per Westermark
Per Westermark is a scholar working on Nephrology, Physiology and Molecular Biology, having authored 372 papers that have together received 23.1k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (214 papers), Alzheimer's disease research and treatments (121 papers), Pancreatic function and diabetes (78 papers), Dermatological and Skeletal Disorders (41 papers), Diabetes Treatment and Management (36 papers), Parathyroid Disorders and Treatments (36 papers), Trace Elements in Health (29 papers) and Prion Diseases and Protein Misfolding (28 papers). The work is most often cited by research in Physiology (9.2k citations), Nephrology (2.1k citations) and Molecular Biology (15.6k citations). Per Westermark has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Gunilla T. Westermark, Knut Sletten, Erik Wilander, Kenneth H. Johnson, Timothy D. O’Brien, Giampaolo Merlini, Gibbons G. Cornwell, Christer Wernstedt, Ulla Engström and Arne Andersson. Their work appears in journals such as Amyloid, Biochemical and Biophysical Research Communications, Scandinavian Journal of Immunology, Diabetologia and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.